IGRT 2016 Madrid

CONCLUSION : Where do we stand?

Attributes

Outcomes Set-up error

Results

Technical performance

Can be quantified and minimized Can be quantified. Correction is investigational Can be quantified and corrected

Intra-fraction organ motion

Inter-fraction organ motion

Feasibility

Patient compliance

Fair

Learning curve

Steep

Cost

Expensive

Significant reduction

Safety

Acute AE/Toxicity Late AE/Toxicity Surrogate outcomes -Biochemical control Secondary outcomes -DFS -QOL Primary outcomes -DSS

Data not mature

Clinical efficacy

No robust data yet Adaptive> daily IGRT??? Significant positive impact on QOL

No robust data yet